Hepatitis B and C Within the Chinese Community in Milan (NCT07241962) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Hepatitis B and C Within the Chinese Community in Milan
1,000 participantsStarted 2025-12
Plain-language summary
The goal of this observational study is to assess the effectiveness of targeted screening for Hepatitis B (HBV) and Hepatitis C (HCV) infections in adults aged 18 to 50 from the Chinese community residing in Milan.
The main questions it aims to answer are:
* Does community-based, culturally sensitive screening increase the detection of undiagnosed HBV and HCV infections in this high-risk population?
* What is the level of adherence, satisfaction and awareness regarding rapid testing methods in this community?
Participants will:
* Receive pre-test counseling in Italian or Chinese with the help of an interpreter
* Complete a brief, anonymous questionnaire on demographics, risk factors and awareness of HBV/HCV
* Undergo capillary rapid testing for HBV and/or HCV
* Receive test results during the same visit
* Complete a short post-test satisfaction questionnaire
The study will be conducted in public spaces within Milan's Chinatown, during monthly sessions, until 1,000 participants are enrolled. Each session will last approximately 30-60 minutes per participant.
Who can participate
Age range
18 Years – 50 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults aged 18 to 50 years
* Self-identified as part of the Chinese community residing in Milan
* Willing and able to provide informed consent
* Willing to undergo HBV and/or HCV rapid screening (capillary blood test)
* Able to complete an anonymous questionnaire on demographics, risk factors and awareness of HBV and HCV infections
* Able to communicate in Italian or Chinese (with interpreter assistance, if needed)
Exclusion Criteria:
* Age under 18 or over 50 years
* Not from the Chinese community or not residing in Milan
* Unable to provide informed consent
* Currently undergoing treatment for HBV or HCV, or with previously confirmed diagnosis of HBV or HCV
* Severe mental or physical illness impairing participation or understanding of consent
* Unable to respond to the questionnaire, even with interpreter assistance
* Pregnant women
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.